Neuroscience
New drug shows promise against multiple sclerosis
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number ...
Nov 1, 2011
0
0
